2 most recent filings and news items mentioning PTCT. Updated every 60 seconds.
OfferingJun 16, 2026Positive
PTC Therapeutics announced pricing of $500 million in 0% convertible senior notes due 2031, with net proceeds to refinance $222 million of 2026 convertible notes. The offering includes a 40% conversion premium and represents a refinancing strategy to extend debt maturity while ma
View filing at SEC.gov →
LeadershipJun 9, 2026Neutral
PTC Therapeutics has engaged former Board member Alethia Young as an independent consultant effective June 8, 2026, following her resignation from the board. The agreement outlines advisory services to management and the board with standard confidentiality and intellectual proper
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.